Manijeh Daneshmand

University of Ottawa — Canada

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index5.9kcitations67works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(30), Viral Infectious Diseases and Gene Expression in Insects(23), Cancer Research and Treatments(23), CAR-T cell therapy research(5), Cancer-related Molecular Pathways(4)

Publications67 total

CD8 T Cell Hyperfunction and Reduced Tumour Control in Murine Models of Advanced Liver Disease
European Journal of Immunology·2025Open Access
Mapping Staphylococcus aureus at Early and Late Stages of Infection in a Clinically Representative Hip Prosthetic Joint Infection Rat Model
Microorganisms·2024Open Access
CD8 T cell hyperfunction and reduced tumour control in models of advanced liver fibrosis
2023Open Access
Supplementary Methods from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 3 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 2 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Data from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 2 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Table 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 4 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Video 2 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Data from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 3 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 4 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Video 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Figure 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Table 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Methods from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
Supplementary Video 1 from Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
2023Open Access
page 1 of 4Next →

Frequent Co-authors

John C. Bell(20), David H. Kirn(18), Caroline J. Breitbach(17), Anne Moon(13), Naomi De Silva(12), Tae-Ho Hwang(10), Rozanne Arulanandam(10), Christina Addison(10), Ian A.J. Lorimer(10), Jeong Heo(9), Mong Cho(9), Carolina S. Ilkow(9), Fernando A. Angarita(9), Jennifer Hanson(9), Ian Lorimer(8), Steve H. Thorne(8), Hannah Chen(8), Richard B. Patt(7), James Burke(7), Derek J. Jonker(6)